ArticleJournal of medicinal chemistry2026

Utilizing the HiBiT System to Identify CARM1 Degraders for Targeted Cancer Therapy.

Megan Bacabac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.